title: Melanoma brain metastases: an unmet challenge in the era of active therapy.
abstract: Metastatic disease to the brain is a frequent manifestation of melanoma and is associated with significant morbidity and mortality and poor prognosis. Surgery and stereotactic radiosurgery provide local control but less frequently affect the overall outcome of melanoma brain metastases (MBM). The role of systemic therapies for active brain lesions has been largely underinvestigated, and patients with active brain lesions are excluded from the vast majority of clinical trials. The advent of active systemic therapy has revolutionized the care of melanoma patients, but this benefit has not been systematically translated into intracranial activity. In this article, we review the biology and clinical outcomes of patients with MBM, and the evidence supporting the use of radiation, surgery, and systemic therapy in MBM. Prospective studies that included patients with active MBM have shown clinical intracranial activity that parallels systemic activity and support the inclusion of patients with active MBM in clinical trials involving novel agents and combination therapies.
authors: Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
authors: Vikram
authors: V
authors: Gorantla
authors: John M
authors: JM
authors: Kirkwood
authors: Hussein A
authors: HA
authors: Tawbi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary* / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008545:Melanoma / Q000556:secondary* / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D016634:Radiosurgery / Q000379:methods
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors
references: Neoplasia. 2010 Sep;12(9):748-54
references: 20824051
references: N Engl J Med. 2011 Jun 30;364(26):2507-16
references: 21639808
references: J Clin Oncol. 2004 Jun 1;22(11):2101-7
references: 15169796
references: Cancer. 1978 Aug;42(2):660-8
references: 679158
references: Eur J Cancer. 1978 Apr;14(4):327-30
references: 648555
references: Cancer. 2007 Sep 15;110(6):1329-37
references: 17623835
references: Nat Med. 2010 Jan;16(1):116-22
references: 20023634
references: N Engl J Med. 1990 Feb 22;322(8):494-500
references: 2405271
references: J Neurosurg. 2011 Mar;114(3):769-79
references: 20524829
references: J Immunother. 2012 Oct;35(8):641-9
references: 22996370
references: J Cancer Res Clin Oncol. 2002 Apr;128(4):214-8
references: 11935312
references: Neuro Oncol. 2008 Apr;10(2):199-207
references: 18287337
references: Cancer. 1980 Feb 15;45(4):679-83
references: 6766793
references: Pigment Cell Melanoma Res. 2011 Aug;24(4):666-72
references: 21615881
references: Br J Cancer. 2004 Aug 31;91(5):829-33
references: 15305201
references: J Natl Compr Canc Netw. 2008 May;6(5):505-13; quiz 514
references: 18492462
references: JAMA. 2006 Jun 7;295(21):2483-91
references: 16757720
references: N Engl J Med. 2010 Aug 19;363(8):711-23
references: 20525992
references: Lancet. 2004 May 22;363(9422):1665-72
references: 15158627
references: Clin Exp Metastasis. 2008;25(7):799-810
references: 18649117
references: Cancer. 2012 Aug 15;118(16):4014-23
references: 22180178
references: Ann Biomed Eng. 2011 Aug;39(8):2223-2241
references: 21556948
references: Br J Cancer. 1997;76(2):256-9
references: 9231928
references: Cancer Res. 1971 Jun;31(6):830-3
references: 5088486
references: Cancer. 1990 Nov 1;66(9):1873-8
references: 2224783
references: J Neurosurg. 2002 Mar;96(3):552-8
references: 11883841
references: Chemotherapy. 1989;35(5):313-9
references: 2791708
references: Lancet Oncol. 2012 Sep;13(9):879-86
references: 22894884
references: Oncogene. 2003 Jun 5;22(23):3616-23
references: 12789270
references: J Neurosurg. 1993 Aug;79(2):210-6
references: 8331402
references: J Neurooncol. 2010 Jan;96(1):103-14
references: 19957014
references: J Neuroimmunol. 1998 Aug 14;89(1-2):104-12
references: 9726832
references: Cancer Res. 2000 Sep 1;60(17):4767-70
references: 10987284
references: Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51
references: 9128946
references: Cancer. 2002 May 15;94(10):2698-705
references: 12173339
references: J Neurooncol. 2008 May;87(3):299-307
references: 18157648
references: Expert Opin Ther Targets. 2007 Nov;11(11):1473-91
references: 18028011
references: J Neurooncol. 2006 Jan;76(1):59-64
references: 16132502
references: J Clin Oncol. 2012 Jul 10;30(20):2522-9
references: 22614978
references: Cancer Res. 2008 Jun 15;68(12):4500-5
references: 18559492
references: Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106
references: 15234044
references: Neuro Oncol. 2004 Apr;6(2):154-65
references: 15134630
references: Int J Radiat Oncol Biol Phys. 1982 Jul;8(7):1131-4
references: 7118615
references: Nat Rev Clin Oncol. 2011 Jun;8(6):344-56
references: 21487419
references: J Neurosurg. 1998 Jan;88(1):11-20
references: 9420067
references: Radiat Oncol. 2012 Aug 02;7:130
references: 22857154
references: Cancer. 1996 Oct 1;78(7):1470-6
references: 8839553
references: Clin Cancer Res. 2004 Jun 1;10(11):3728-36
references: 15173079
references: PLoS One. 2012;7(3):e33571
references: 22442699
references: Lancet Oncol. 2012 May;13(5):459-65
references: 22456429
references: Lancet. 2012 May 19;379(9829):1893-901
references: 22608338
references: Clin Cancer Res. 2010 Oct 1;16(19):4892-8
references: 20719934
references: Cancer. 2011 Apr 15;117(8):1697-703
references: 21472716
references: Cancer. 2007 Jun 15;109(12):2515-21
references: 17487853
references: Cancer. 2011 Apr 15;117(8):1687-96
references: 20960525
references: Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):581-9
references: 9806518
references: J Clin Invest. 2010 May;120(5):1368-79
references: 20440079
references: J Clin Oncol. 2011 Apr 1;29(10):1239-46
references: 21343559
references: Cancer. 2007 Feb 1;109(3):455-64
references: 17200963
references: Transl Oncol. 2010 Dec 01;3(6):380-8
references: 21151477
references: Clin Cancer Res. 1999 Nov;5(11):3549-59
references: 10589771
references: Cancer Res. 2002 Jan 15;62(2):341-5
references: 11809675
references: Ann Oncol. 2010 Mar;21(3):655-661
references: 19767314
references: J Clin Oncol. 2001 Aug 15;19(16):3622-34
references: 11504744
references: Cancer Res. 2006 Mar 15;66(6):3188-96
references: 16540670
references: Int J Cancer. 2001 Apr 15;92(2):176-80
references: 11291042
references: J Clin Oncol. 2004 Apr 1;22(7):1293-300
references: 15051777
references: Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1277-87
references: 11955740
references: Cancer. 1996 Oct 15;78(8):1781-8
references: 8859192
references: Cancer. 2007 May 1;109(9):1855-62
references: 17351953
references: Int J Cancer. 2012 Sep 1;131(5):1071-82
references: 22025079
references: Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):427-34
references: 10487566
references: Br J Cancer. 2007 Jan 15;96(1):44-8
references: 17146474
references: Cancer. 2011 Apr 15;117(8):1711-20
references: 21472718
references: Nature. 2009 Jun 18;459(7249):1005-9
references: 19421193
references: J Surg Oncol. 2011 Aug 1;104(2):111-5
references: 21381040
references: Br J Cancer. 2011 Jun 7;104(12):1816-21
references: 21610711
references: Lancet Oncol. 2012 Nov;13(11):1087-95
references: 23051966
references: J Clin Oncol. 2004 Jul 15;22(14):2865-72
references: 15254054
references: J Immunother. 2002 Jan-Feb;25(1):82-7
references: 11924913
references: Anticancer Res. 2009 Oct;29(10):4189-93
references: 19846971
references: Cancer Control. 2009 Jul;16(3):248-55
references: 19556965
references: Lancet Oncol. 2013 Mar;14(3):249-56
references: 23414587
references: Br J Cancer. 2010 Apr 13;102(8):1213-8
references: 20372154
references: J Clin Oncol. 2008 Nov 10;26(32):5233-9
references: 18809613
references: Cancer Res. 1991 Apr 15;51(8):2029-35
references: 1826230
references: BMC Cancer. 2011 Apr 17;11:142
references: 21496312
references: Clin Cancer Res. 2009 Dec 15;15(24):7538-7546
references: 19996208
references: Oncology. 2002;63(4):333-7
references: 12417787
references: J Cell Biochem. 2010 Dec 1;111(5):1299-309
references: 20803552
references: Nat Rev Drug Discov. 2009 Nov;8(11):892-909
references: 19876042
references: Neurosurgery. 2008 Feb;62 Suppl 2:790-801
references: 18596426
references: Brain Pathol. 2009 Oct;19(4):573-85
references: 18662234
references: CA Cancer J Clin. 2013 Jan;63(1):11-30
references: 23335087
references: J Immunol. 2006 Dec 15;177(12):8448-55
references: 17142742
references: Cancer. 2002 Apr 15;94(8):2265-72
references: 12001126
references: Ann Neurol. 1993 Jun;33(6):583-90
references: 8498838
references: Cancer Res. 2003 Sep 1;63(17):5408-13
references: 14500375
references: J Neurooncol. 2010 Jan;96(1):97-102
references: 19957015